199 related articles for article (PubMed ID: 37667051)
21. Long non-coding RNA AGAP2-AS1 exerts oncogenic properties in glioblastoma by epigenetically silencing TFPI2 through EZH2 and LSD1.
Luo W; Li X; Song Z; Zhu X; Zhao S
Aging (Albany NY); 2019 Jun; 11(11):3811-3823. PubMed ID: 31186379
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA-137 is downregulated in glioblastoma and inhibits the stemness of glioma stem cells by targeting RTVP-1.
Bier A; Giladi N; Kronfeld N; Lee HK; Cazacu S; Finniss S; Xiang C; Poisson L; deCarvalho AC; Slavin S; Jacoby E; Yalon M; Toren A; Mikkelsen T; Brodie C
Oncotarget; 2013 May; 4(5):665-76. PubMed ID: 23714687
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of tumor progression and M2 microglial polarization by extracellular vesicle-mediated microRNA-124 in a 3D microfluidic glioblastoma microenvironment.
Hong S; You JY; Paek K; Park J; Kang SJ; Han EH; Choi N; Chung S; Rhee WJ; Kim JA
Theranostics; 2021; 11(19):9687-9704. PubMed ID: 34646393
[No Abstract] [Full Text] [Related]
24. ADAMDEC1 Maintains a Growth Factor Signaling Loop in Cancer Stem Cells.
Jimenez-Pascual A; Hale JS; Kordowski A; Pugh J; Silver DJ; Bayik D; Roversi G; Alban TJ; Rao S; Chen R; McIntyre TM; Colombo G; Taraboletti G; Holmberg KO; Forsberg-Nilsson K; Lathia JD; Siebzehnrubl FA
Cancer Discov; 2019 Nov; 9(11):1574-1589. PubMed ID: 31434712
[TBL] [Abstract][Full Text] [Related]
25. miR-135b suppresses tumorigenesis in glioblastoma stem-like cells impairing proliferation, migration and self-renewal.
Lulli V; Buccarelli M; Martini M; Signore M; Biffoni M; Giannetti S; Morgante L; Marziali G; Ilari R; Pagliuca A; Larocca LM; De Maria R; Pallini R; Ricci-Vitiani L
Oncotarget; 2015 Nov; 6(35):37241-56. PubMed ID: 26437223
[TBL] [Abstract][Full Text] [Related]
26. A curcumin derivative hydrazinobenzoylcurcumin suppresses stem-like features of glioblastoma cells by targeting Ca
Shin HJ; Lee S; Jung HJ
J Cell Biochem; 2019 Apr; 120(4):6741-6752. PubMed ID: 30390339
[TBL] [Abstract][Full Text] [Related]
27. Expression profiling of single cells and patient cohorts identifies multiple immunosuppressive pathways and an altered NK cell phenotype in glioblastoma.
Close HJ; Stead LF; Nsengimana J; Reilly KA; Droop A; Wurdak H; Mathew RK; Corns R; Newton-Bishop J; Melcher AA; Short SC; Cook GP; Wilson EB
Clin Exp Immunol; 2020 Apr; 200(1):33-44. PubMed ID: 31784984
[TBL] [Abstract][Full Text] [Related]
28. The MAP3K1/c-JUN signaling axis regulates glioblastoma stem cell invasion and tumor progression.
Zhou S; Niu R; Sun H; Kim SH; Jin X; Yin J
Biochem Biophys Res Commun; 2022 Jul; 612():188-195. PubMed ID: 35567901
[TBL] [Abstract][Full Text] [Related]
29. Combined PDK1 and CHK1 inhibition is required to kill glioblastoma stem-like cells in vitro and in vivo.
Signore M; Pelacchi F; di Martino S; Runci D; Biffoni M; Giannetti S; Morgante L; De Majo M; Petricoin EF; Stancato L; Larocca LM; De Maria R; Pallini R; Ricci-Vitiani L
Cell Death Dis; 2014 May; 5(5):e1223. PubMed ID: 24810059
[TBL] [Abstract][Full Text] [Related]
30. Hypoxia-driven protease legumain promotes immunosuppression in glioblastoma.
Pang L; Guo S; Khan F; Dunterman M; Ali H; Liu Y; Huang Y; Chen P
Cell Rep Med; 2023 Nov; 4(11):101238. PubMed ID: 37858339
[TBL] [Abstract][Full Text] [Related]
31. ARS2/MAGL signaling in glioblastoma stem cells promotes self-renewal and M2-like polarization of tumor-associated macrophages.
Yin J; Kim SS; Choi E; Oh YT; Lin W; Kim TH; Sa JK; Hong JH; Park SH; Kwon HJ; Jin X; You Y; Kim JH; Kim H; Son J; Lee J; Nam DH; Choi KS; Shi B; Gwak HS; Yoo H; Iavarone A; Kim JH; Park JB
Nat Commun; 2020 Jun; 11(1):2978. PubMed ID: 32532977
[TBL] [Abstract][Full Text] [Related]
32. MEK5-ERK5 Axis Promotes Self-renewal and Tumorigenicity of Glioma Stem Cells.
Fukasawa K; Lyu J; Kubo T; Tanaka Y; Suzuki A; Horie T; Tomizawa A; Osumi R; Iwahashi S; Tokumura K; Murata M; Kobayashi M; Todo T; Hirao A; Hinoi E
Cancer Res Commun; 2023 Jan; 3(1):148-159. PubMed ID: 36968222
[TBL] [Abstract][Full Text] [Related]
33. Activation of estrogen receptor beta signaling reduces stemness of glioma stem cells.
Sareddy GR; Pratap UP; Venkata PP; Zhou M; Alejo S; Viswanadhapalli S; Tekmal RR; Brenner AJ; Vadlamudi RK
Stem Cells; 2021 May; 39(5):536-550. PubMed ID: 33470499
[TBL] [Abstract][Full Text] [Related]
34. Activation of the Receptor Tyrosine Kinase AXL Regulates the Immune Microenvironment in Glioblastoma.
Sadahiro H; Kang KD; Gibson JT; Minata M; Yu H; Shi J; Chhipa R; Chen Z; Lu S; Simoni Y; Furuta T; Sabit H; Zhang S; Bastola S; Yamaguchi S; Alsheikh H; Komarova S; Wang J; Kim SH; Hambardzumyan D; Lu X; Newell EW; DasGupta B; Nakada M; Lee LJ; Nabors B; Norian LA; Nakano I
Cancer Res; 2018 Jun; 78(11):3002-3013. PubMed ID: 29531161
[TBL] [Abstract][Full Text] [Related]
35. Exosomal miR-6733-5p mediates cross-talk between glioblastoma stem cells and macrophages and promotes glioblastoma multiform progression synergistically.
Huang S; Liu L; Xu Z; Liu X; Wu A; Zhang X; Li Z; Li S; Li Y; Yuan J; Cheng S; Li H; Dong J
CNS Neurosci Ther; 2023 Dec; 29(12):3756-3773. PubMed ID: 37309294
[TBL] [Abstract][Full Text] [Related]
36. Reprogramming Transcription Factors Oct4 and Sox2 Induce a BRD-Dependent Immunosuppressive Transcriptome in GBM-Propagating Cells.
Ma T; Hu C; Lal B; Zhou W; Ma Y; Ying M; Prinos P; Quiñones-Hinojosa A; Lim M; Laterra J; Li Y
Cancer Res; 2021 May; 81(9):2457-2469. PubMed ID: 33574085
[TBL] [Abstract][Full Text] [Related]
37. Programmed Cell Death 10 Mediated CXCL2-CXCR2 Signaling in Regulating Tumor-Associated Microglia/Macrophages Recruitment in Glioblastoma.
Zhang Q; Wang J; Yao X; Wu S; Tian W; Gan C; Wan X; You C; Hu F; Zhang S; Zhang H; Zhao K; Shu K; Lei T
Front Immunol; 2021; 12():637053. PubMed ID: 34108959
[TBL] [Abstract][Full Text] [Related]
38. TRIM24 promotes stemness and invasiveness of glioblastoma cells via activating Sox2 expression.
Zhang LH; Yin YH; Chen HZ; Feng SY; Liu JL; Chen L; Fu WL; Sun GC; Yu XG; Xu DG
Neuro Oncol; 2020 Dec; 22(12):1797-1808. PubMed ID: 32492707
[TBL] [Abstract][Full Text] [Related]
39. Morusin inhibits glioblastoma stem cell growth in vitro and in vivo through stemness attenuation, adipocyte transdifferentiation, and apoptosis induction.
Guo H; Liu C; Yang L; Dong L; Wang L; Wang Q; Li H; Zhang J; Lin P; Wang X
Mol Carcinog; 2016 Jan; 55(1):77-89. PubMed ID: 25557841
[TBL] [Abstract][Full Text] [Related]
40. Combined inhibition of AKT/mTOR and MDM2 enhances Glioblastoma Multiforme cell apoptosis and differentiation of cancer stem cells.
Daniele S; Costa B; Zappelli E; Da Pozzo E; Sestito S; Nesi G; Campiglia P; Marinelli L; Novellino E; Rapposelli S; Martini C
Sci Rep; 2015 Apr; 5():9956. PubMed ID: 25898313
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
